Basics Neumora Therapeutics, Inc. IPO Date: September 15, 2023 Sector: Healthcare Industry: Biotech Market Cap: $113.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.43% Avg Daily Range (30 D): $0.03 | 3.93% Avg Daily Range (90 D): $0.04 | 3.74% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): .71M Avg Daily Volume (90 D): 1.12M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 176 Avg Trade Size (Sh.) (90 D): 191 Institutional Trades Total Inst.Trades: 284 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.01M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.32M Avg Closing Trade (30 D): $1.01M Avg Closing Trade (90 D): $.82M Avg Closing Volume: 248.44K         News May 28, 2025 @ 1:45 AM Kuehn Law Encourages Investors of Grocery Outlet H... Source: N/A May 28, 2025 @ 1:40 AM Kuehn Law Encourages Investors of Neumora Therapeu... Source: N/A Apr 6, 2025 @ 1:35 PM Faruqi & Faruqi Reminds Neumora Therapeutics Inves... Source: N/A Apr 2, 2025 @ 9:30 PM NMRA Deadline in 5 Days: Kessler Topaz Meltzer & C... Source: N/A Apr 2, 2025 @ 8:00 PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.42 $-.45 Diluted EPS $-.42 $-.45 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -67.99M $ -72.55M Operating Income / Loss $ $ -70.94M $ -76.65M Cost of Revenue $ $ $ Net Cash Flow $ $ M $ 125.04M PE Ratio